87

Hematology&Oncology
Sub Categories on Hematology&Oncology
Latest Articles
Single-drug treatments are giving way to combination therapy for lung cancer

Single-drug treatments are giving way to combination therapy for lung cancer

by Kathy Katella,Yale UniversityCredit: Unsplash/CC0 Public DomainCombination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means tr

Single-drug treatments are giving way to combination therapy for lung cancer

by Kathy Katella,Yale UniversityCredit: Unsplash/CC0 Public DomainCombination therapy is essentially a one-two punch at cancer—sometimes with multiple punches. For people with lung cancer, it means tr
Molecular test for bile duct cancer nearly doubles detection rate

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de

Molecular test for bile duct cancer nearly doubles detection rate

byUniversity of PittsburghCredit: Pixabay/CC0 Public DomainWhen patients develop a narrowing or blockage in the bile ducts—the tubes connecting the liver, gallbladder and intestines—physicians must de
Strongest evidence yet that vaping likely causes cancer

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth

Strongest evidence yet that vaping likely causes cancer

by Bernard Stewart,The ConversationCredit: Unsplash/CC0 Public DomainAs early as the 1880s,there was evidencethat smoking tobacco damaged your lungs. But it took almost 100 years todefinitively showth
Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000

Targeted screening blitz could bring Indigenous cervical cancer elimination to 2036

byAustralian National UniversityPredicted cervical cancer incidence (age standardized, per 100,000 females) between 2020 and 2100. Credit:The Lancet Public Health(2026). DOI: 10.1016/s2468-2667(26)000
Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu

Targeted therapy improves long-term outcomes for patients with rare mutations driving lung cancer

byMass General BrighamCredit: Unsplash/CC0 Public DomainIn some non-small cell lung cancers (NSCLCs), changes to the RET gene (known as RET fusions) can drive tumor growth. In a phase 1/2 clinical stu
First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche

First-in-class radio-theranostic utilizes novel antibody to target B7-H3 proteins in cancer cells

byUniversity of Texas MD Anderson Cancer CenterDevelopment of a high affinity, 4Ig-isoform selective antibody for beta-radioligand therapy. Credit:Theranostics(2026). DOI: 10.7150/thno.123285Researche
FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a

FDA-approved oral AML therapy could let older patients avoid monthly infusion visits

byWeill Cornell Medical CollegeCredit: Unsplash/CC0 Public DomainThe ASCERTAIN V clinical trial demonstrated that an all-oral drug combination for older patients with acute myeloid leukemia (AML) is a
RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc

RAS(ON) inhibitor doubles median overall survival in patients with metastatic pancreatic cancer

byDana-Farber Cancer InstituteAxial CT image with i.v. contrast. Macrocystic adenocarcinoma of the pancreatic head. Credit: public domainA shift in the way people think about and treat pancreatic canc
New theranostic approach effectively detects and treats neuroendocrine prostate cancer

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe

New theranostic approach effectively detects and treats neuroendocrine prostate cancer

by Society of Nuclear Medicine and Molecular ImagingRET-targeted PET tracer highlights neuroendocrine prostate cancer tumors. Representative PET imaging shows strong tumor uptake of the RET-binding pe